BackEuropean Biotech Acquisition - Warrants (06/03/2026) Overview

European Biotech Acquisition - Warrants (06/03/2026) Current Cash

European Biotech Acquisition - Warrants (06/03/2026)'s current cash is $310K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$308488.00
64.47% YoYΔ $-559792.00 vs prior year quarter

Peer average

Loading

European Biotech Acquisition - Warrants (06/03/2026) Current Cash History

Loading

European Biotech Acquisition - Warrants (06/03/2026) vs. peers: Current Cash Comparison

Loading

European Biotech Acquisition - Warrants (06/03/2026) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

European Biotech Acquisition - Warrants (06/03/2026) (EBACW) FAQ

As of the most recent data (December 2022), EBACW shows a current cash of $310K. That compares with $870K in the prior-year period — down 64.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EBACW's current cash is now $310K (was $870K) — a 64.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether European Biotech Acquisition - Warrants (06/03/2026) is outperforming or lagging.

Tracking EBACW's current cash over time shows whether European Biotech Acquisition - Warrants (06/03/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $310K That compares with $870K in the prior-year period — down 64.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has European Biotech Acquisition - Warrants (06/03/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $310K) with ownership activity and broader fundamentals.